In re Copaxone 40 mg Consolidated Cases

14-CV-01171 (GMS) (D.Del.) Successful invalidation of all claims in patent infringement action regarding Amneal’s ANDA to make a generic version of Teva’s MS product Copaxone® 40 mg.

View All Results
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.